As of January 2025, Realcan Pharmaceutical Group has a market cap of $618.71M. This makes Realcan Pharmaceutical Group the world's 10126th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $484.66M | -28.13% |
2023 | $674.40M | -20.63% |
2022 | $849.70M | 4.83% |
2021 | $810.51M | -24.86% |
2020 | $1.08B | -31.99% |
2019 | $1.59B | 10.33% |
2018 | $1.44B | -48.18% |
2017 | $2.77B | -4.67% |
2016 | $2.91B | -9.64% |
2015 | $3.22B | 122.15% |
2014 | $1.45B | 27.58% |
2013 | $1.14B | 53.58% |
2012 | $739.77M | - |